In Vitro Activity of Ramoplanin against Clostridium difficile, Including Strains with Reduced Susceptibility to Vancomycin or with Resistance to Metronidazole

We evaluated the in vitro activity of ramoplanin, an antimicrobial compound that inhibits cell wall synthesis by acting at the level of lipid intermediate formation, against Clostridium difficile. We included strains with reduced susceptibilities to vancomycin (vancomycin-intermediate [Van(i)] strai...

Descripció completa

Dades bibliogràfiques

Publicat a:	Antimicrob Agents Chemother
Autors principals:	Peláez, T., Alcalá, L., Alonso, R., Martín-López, A., García-Arias, V., Marín, M., Bouza, E.
Format:	Artigo
Idioma:	Inglês
Publicat:	American Society for Microbiology (ASM) 2005
Matèries:	Susceptibility
Accés en línia:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC549223/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/15728918/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/AAC.49.3.1157-1159.2005
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!